Research progress of vascular endothelial growth factor-A and its isoforms in kidney disease.
- Author:
Jing JING
1
;
Xin ZHONG
1
;
Bi-Cheng LIU
1
;
Lin-Li LYU
2
Author Information
1. Institute of Nephrology, Zhongda Hospital, Southeast University, Nanjing 210009, China.
2. Institute of Nephrology, Zhongda Hospital, Southeast University, Nanjing 210009, China. lvlinli@seu.edu.cn.
- Publication Type:Review
- MeSH:
Humans;
Kidney/metabolism*;
Kidney Diseases;
Protein Isoforms/metabolism*;
Vascular Endothelial Growth Factor A/physiology*
- From:
Acta Physiologica Sinica
2022;74(1):59-66
- CountryChina
- Language:Chinese
-
Abstract:
Vascular endothelial growth factor-A (VEGF-A) is a critical angiogenic factor which is mainly secreted from podocytes and epithelial cells in kidney and plays an important role in renal pathophysiology. In recent years, functions of different isoforms of VEGF-A and the new secretion approach via extracellular vesicles (EVs) have been identified. Thus, further understanding are needed for the role of VEGF-A and its isoforms in renal injury and repair. In this review, we summarized the expression, secretion and regulation of VEGF-A, its biological function, and the role of different isoforms of VEGF-A in the development of different renal diseases. Meanwhile, the research progress of VEGF-A as diagnostic marker and therapeutic target for renal diseases were discussed.
